Sniping, Not Debating: The Center for Medical Progress Videos

The following guest post comes to us via a Planned Parenthood Arizona volunteer.

health care providersI watched or read the first few full-length videos and transcripts posted by the Center for Medical Progress (CMP) beginning July 25, 2015. No doubt, coming weeks will bring more videos, but I would be surprised if they stray from themes of this first batch. In a nutshell, the heavily edited videos assert that uncompassionate Planned Parenthood representatives violate laws against collecting and selling fetal tissue for profit, “haggle” over pricing, and discuss abortion procedures and tissue in a distasteful, chilling manner.

I’m pretty weary of (though never surprised by) folks who oppose a woman’s right to make her own child-bearing decisions. Why? In this case, opponents refuse to stand and fight on the merits of their arguments. Instead, they use sniping tactics that trigger emotions and ignore facts.

CMP selected snippets of their hidden-camera videos to concoct a narrative not supported by the unedited videos. Consider these snippets they left out.

Planned Parenthood affiliates help WOMEN donate THEIR fetal tissue for medical research.

Dr. Deborah Nucatola, Planned Parenthood Federation of America’s senior director of medical services, spoke of the demand for fetal tissue donation programs:

“Patients will call up, make an appointment, and say, ‘I would like to donate my tissue.’ And the affiliates are really feeling like, ‘Oh, wow, I really need to figure out a way to get this done.’ Because patients are talking about — you know, in general, in health care, a provider is not going to offer a service unless there’s demand. And there is a demand now, I mean, women know that this is something that they can do.”

Continue reading

STD Awareness: The Future of Treatment for HIV/AIDS

This scanning electron micrograph shows HIV particles (colored yellow) infecting a human T cell. Image: National Institute of Allergy and Infectious Diseases, National Institutes of Health

This scanning electron micrograph shows HIV particles (colored yellow) infecting a human T cell. Image: National Institute of Allergy and Infectious Diseases, National Institutes of Health

In 2006, an HIV-positive man was diagnosed with leukemia. First he received chemotherapy, and when the cancer returned his doctor recommended a stem-cell transplant with tissues obtained from a bone-marrow donor. After finding an unusually high number of compatible donors, his doctor, Gero Hütter, had a simple idea that would change the course of HIV research. Dr. Hütter knew of a rare genetic mutation that confers immunity to many strains of HIV, including the strain that infected his cancer patient. And new blood cells, including immune cells, are manufactured by bone marrow. What if he could find a bone-marrow donor with this mutation? What effect would it have on the HIV infection?

Five years after his cancer diagnosis, the man, known as the Berlin patient and recently identified as Timothy Ray Brown, is in remission from cancer … and the most sensitive tests have been unable to detect HIV anywhere in his body, despite the discontinuation of antiretroviral drugs. Scientists are a cautious lot, careful not to make grand statements without qualifying them with words like “seem” and “suggest.” But more and more, researchers are starting to say that Brown could be the first case in which a cure for HIV was attained.

Human immunodeficiency virus, or HIV, has been the focus of intense research since the 1980s, when it was identified as the causative agent of AIDS. Many anti-HIV drugs have been developed since then, though worldwide, less than a third of people who need the drugs have access to them. Those with access, however, have significantly improved health outcomes and longer life expectancy. Continue reading